364 related articles for article (PubMed ID: 23644187)
1. Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain.
Khasabova IA; Holman M; Morse T; Burlakova N; Coicou L; Harding-Rose C; Simone DA; Seybold VS
Neurobiol Dis; 2013 Oct; 58():19-28. PubMed ID: 23644187
[TBL] [Abstract][Full Text] [Related]
2. A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain.
Khasabova IA; Khasabov SG; Harding-Rose C; Coicou LG; Seybold BA; Lindberg AE; Steevens CD; Simone DA; Seybold VS
J Neurosci; 2008 Oct; 28(44):11141-52. PubMed ID: 18971457
[TBL] [Abstract][Full Text] [Related]
3. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
Starowicz K; Makuch W; Korostynski M; Malek N; Slezak M; Zychowska M; Petrosino S; De Petrocellis L; Cristino L; Przewlocka B; Di Marzo V
PLoS One; 2013; 8(4):e60040. PubMed ID: 23573230
[TBL] [Abstract][Full Text] [Related]
4. A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis.
Malek N; Mrugala M; Makuch W; Kolosowska N; Przewlocka B; Binkowski M; Czaja M; Morera E; Di Marzo V; Starowicz K
Pain; 2015 May; 156(5):890-903. PubMed ID: 25719612
[TBL] [Abstract][Full Text] [Related]
5. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.
Khasabova IA; Khasabov S; Paz J; Harding-Rose C; Simone DA; Seybold VS
J Neurosci; 2012 May; 32(20):7091-101. PubMed ID: 22593077
[TBL] [Abstract][Full Text] [Related]
7. Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis.
Uhelski ML; Gupta K; Simone DA
Pain; 2017 Sep; 158(9):1711-1722. PubMed ID: 28570479
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy.
Uhelski ML; Khasabova IA; Simone DA
J Neurophysiol; 2015 Mar; 113(5):1501-10. PubMed ID: 25505113
[TBL] [Abstract][Full Text] [Related]
9. Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors.
Millns PJ; Chimenti M; Ali N; Ryland E; de Lago E; Fernandez-Ruiz J; Chapman V; Kendall DA
Eur J Neurosci; 2006 Dec; 24(12):3489-95. PubMed ID: 17229097
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
Spradley JM; Guindon J; Hohmann AG
Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
[TBL] [Abstract][Full Text] [Related]
11. JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy.
Khasabova IA; Yao X; Paz J; Lewandowski CT; Lindberg AE; Coicou L; Burlakova N; Simone DA; Seybold VS
Pharmacol Res; 2014 Dec; 90():67-75. PubMed ID: 25304184
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells.
Li H; Wood JT; Whitten KM; Vadivel SK; Seng S; Makriyannis A; Avraham HK
Br J Pharmacol; 2013 Oct; 170(3):489-505. PubMed ID: 23347118
[TBL] [Abstract][Full Text] [Related]
13. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K
Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920
[TBL] [Abstract][Full Text] [Related]
14. Modulation of sensory neuron potassium conductances by anandamide indicates roles for metabolites.
Evans RM; Wease KN; MacDonald CJ; Khairy HA; Ross RA; Scott RH
Br J Pharmacol; 2008 May; 154(2):480-92. PubMed ID: 18376419
[TBL] [Abstract][Full Text] [Related]
15. Localization of the endocannabinoid-degrading enzyme fatty acid amide hydrolase in rat dorsal root ganglion cells and its regulation after peripheral nerve injury.
Lever IJ; Robinson M; Cibelli M; Paule C; Santha P; Yee L; Hunt SP; Cravatt BF; Elphick MR; Nagy I; Rice AS
J Neurosci; 2009 Mar; 29(12):3766-80. PubMed ID: 19321773
[TBL] [Abstract][Full Text] [Related]
16. Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain.
Khasabova IA; Chandiramani A; Harding-Rose C; Simone DA; Seybold VS
Pharmacol Res; 2011 Jul; 64(1):60-7. PubMed ID: 21440630
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
[TBL] [Abstract][Full Text] [Related]
18. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
Kinsey SG; Long JZ; O'Neal ST; Abdullah RA; Poklis JL; Boger DL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2009 Sep; 330(3):902-10. PubMed ID: 19502530
[TBL] [Abstract][Full Text] [Related]
19. Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase.
Thors L; Burston JJ; Alter BJ; McKinney MK; Cravatt BF; Ross RA; Pertwee RG; Gereau RW; Wiley JL; Fowler CJ
Br J Pharmacol; 2010 Jun; 160(3):549-60. PubMed ID: 20590565
[TBL] [Abstract][Full Text] [Related]
20. Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and central mechanisms.
Peng X; Studholme K; Kanjiya MP; Luk J; Bogdan D; Elmes MW; Carbonetti G; Tong S; Gary Teng YH; Rizzo RC; Li H; Deutsch DG; Ojima I; Rebecchi MJ; Puopolo M; Kaczocha M
Mol Pain; 2017 Jan; 13():1744806917697007. PubMed ID: 28326944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]